The Impact of Peripheral Cooling on Chemotherapy-Induced Peripheral Neuropathy: An Integrative Review.


Journal

Journal of the advanced practitioner in oncology
ISSN: 2150-0878
Titre abrégé: J Adv Pract Oncol
Pays: United States
ID NLM: 101550346

Informations de publication

Date de publication:
Historique:
entrez: 25 1 2021
pubmed: 26 1 2021
medline: 26 1 2021
Statut: ppublish

Résumé

Chemotherapy-induced peripheral neuropathy (CIPN) is a prevalent, potentially long-lasting side effect of select chemotherapies. It contributes to suboptimal chemotherapy dosing, and its symptoms negatively impact patients' quality of life. To date, interventions to effectively prevent this toxicity have not been established, and interventions to treat CIPN have produced only modest results. The purpose of this integrative review is to examine the impact of regional cooling applied to distal extremities on the severity of CIPN. A literature review was performed using SCOPUS and PubMed databases. The search was not restricted by date but was restricted to English language. Forty-two articles were identified in the search, and six were included in the review after applying inclusion and exclusion criteria. Results related to protective effects from peripheral cooling against CIPN were variable. Four out of six studies demonstrated benefit of peripheral cooling in reducing the severity of CIPN. There was evidence to suggest that applying a relatively greater degree of cooling compared with a lesser degree may confer benefit in reducing the severity of CIPN. Both direct application of cooling and use of compression to achieve fingertip cooling showed potential benefit.

Identifiants

pubmed: 33489425
doi: 10.6004/jadpro.2020.11.8.5
pii: 2020.11.8.5
pmc: PMC7810270
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

845-857

Informations de copyright

© 2020 Harborside™.

Références

Nurs Res. 2007 Sep-Oct;56(5):323-31
pubmed: 17846553
Support Care Cancer. 2016 Nov;24(11):4779-89
pubmed: 27470258
Breast Cancer Res Treat. 2016 Nov;160(1):61-67
pubmed: 27620884
JAMA Dermatol. 2018 Dec 1;154(12):1465-1472
pubmed: 30383138
Front Oncol. 2017 Jan 10;6:274
pubmed: 28119855
Breast Cancer Res Treat. 2013 Nov;142(1):109-18
pubmed: 24132874
Springerplus. 2014 Jul 16;3:366
pubmed: 25089251
J Pharm Health Care Sci. 2016 Nov 15;2:33
pubmed: 27891244
Support Care Cancer. 2012 Mar;20(3):583-9
pubmed: 21380613
Support Care Cancer. 2016 Apr;24(4):1571-81
pubmed: 26384827
J Oncol Pract. 2013 Sep;9(5):e234-40
pubmed: 23943894
Ann Oncol. 2006 Feb;17(2):350
pubmed: 16166175
Nat Rev Neurol. 2010 Dec;6(12):657-66
pubmed: 21060341
Cancer Treat Rev. 2014 Aug;40(7):872-82
pubmed: 24830939
Clin J Oncol Nurs. 2010 Jun;14(3):E22-8
pubmed: 20529785
Support Care Cancer. 2018 Oct;26(10):3461-3469
pubmed: 29681015
Ann Oncol. 2012 Oct;23 Suppl 7:vii167-73
pubmed: 22997449
J Oncol Pharm Pract. 2005 Dec;11(4):159-62
pubmed: 16595069
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Pain. 2014 Dec;155(12):2461-2470
pubmed: 25261162
Oncologist. 2013;18(7):885-91
pubmed: 23650021
J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):636-641
pubmed: 29439162
Support Care Cancer. 2014 Aug;22(8):2261-9
pubmed: 24789421
Acta Oncol. 2016;55(4):430-6
pubmed: 26360921
Cancer. 2008 Apr 1;112(7):1625-31
pubmed: 18286527
J Oncol Pract. 2014 Nov;10(6):e421-e424
pubmed: 29424607
J Natl Cancer Inst. 2018 Feb 1;110(2):141-148
pubmed: 29924336
J Clin Oncol. 2005 Jul 1;23(19):4424-9
pubmed: 15994152

Auteurs

Bethany G Sphar (BG)

The University of Texas MD Anderson Cancer Center, Houston, Texas.

Christi Bowe (C)

The University of Texas MD Anderson Cancer Center, Houston, Texas.

Joyce E Dains (JE)

The University of Texas MD Anderson Cancer Center, Houston, Texas.

Classifications MeSH